The SARS-CoV-2 Rapid Antibody Test is a CE marked lateral flow rapid chromatographic immunoassay intended for qualitative detection of IgM and IgG antibodies to SARS-CoV-2 in human serum, plasma or whole blood.
Similar to laboratory instruments, it detects antibodies that an exposed host has produced in response to exposure to the virus by providing a qualitative result of “yes” or “no” with regards to the presence of IgG and /or IgM antibodies.
The SARS-CoV-2 Rapid Antibody Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating prior infection. It can be performed with a small capillary blood sample (20 μL) from the fingertip or a venous blood vial. This is equivalent to about one or two drops of blood.
Please read our disclaimer for more information